Commonwealth Equity Services
ROIV icon

Commonwealth Equity Services’s Roivant Sciences ROIV Stock Holding History

Commonwealth Equity Services’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$358K Sell
10,117
-6,777
-40% -$200K ﹤0.01% 3617
2026
Q1 		$468K Sell
16,894
-8,860
-34% -$228K ﹤0.01% 3268
2025
Q4 		$559K Sell
25,754
-3,820
-13% -$75.4K ﹤0.01% 3088
2025
Q3 		$447K Sell
29,574
-4,112
-12% -$50.9K ﹤0.01% 3270
2025
Q2 		$380K Sell
33,686
-1,490
-4% -$16.1K ﹤0.01% 3389
2025
Q1 		$355K Buy
35,176
+15,588
+80% +$169K ﹤0.01% 3331
2024
Q4 		$232K Buy
19,588
+3,813
+24% +$45.1K ﹤0.01% 3635
2024
Q3 		$182K Buy
15,775
+1,071
+7% +$12.2K ﹤0.01% 3741
2024
Q2 		$155K Sell
14,704
-4,224
-22% -$46.3K ﹤0.01% 3716
2024
Q1 		$200K Buy
18,928
+1,599
+9% +$17.2K ﹤0.01% 3629
2023
Q4 		$195K Buy
+17,329
New +$169K ﹤0.01% 3520

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Commonwealth Equity Services's ROIV Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Roivant Sciences (ROIV) stake by 40% in Q2 2026, selling an estimated $200K and leaving 10,117 shares worth $358K. The position accounts for ﹤0.01% of the portfolio, ranked #3617.

Commonwealth Equity Services first reported a position in ROIV in Q4 2023 and has held it in 11 quarters since. The position peaked at $559K in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Commonwealth Equity Services held 10,117 shares of Roivant Sciences worth $358K as of Q2 2026.
  • Commonwealth Equity Services sold 6,777 Roivant Sciences shares in Q2 2026, an estimated $200K.
  • Roivant Sciences made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3617 holding.
  • Commonwealth Equity Services first reported a position in Roivant Sciences in Q4 2023 and has held it in 11 quarters since.
  • Commonwealth Equity Services's Roivant Sciences position peaked at $559K in Q4 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.